Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Transfusion ; 56(9): 2286-95, 2016 09.
Article in English | MEDLINE | ID: mdl-27443848

ABSTRACT

BACKGROUND: Pathogen inactivation (PI) techniques use ultraviolet (UV) illumination with or without a photosensitizer to destroy pathogen RNA and DNA. Although lacking a nucleus and innate DNA transcription, platelets (PLTs) contain RNA and can synthesize proteins. The impact of PI on PLT protein synthesis and function is unknown; altered synthesis may affect overall PLT quality. In this study we determine to what extent PLT RNA is affected by PI. STUDY DESIGN AND METHODS: In a pool-and-split design, paired apheresis PLT concentrates were treated with riboflavin and UV illumination or were left untreated. PLT total RNA and mRNA amounts specific for glycoproteins (GP)IIIa, GPIIb, and GPIb; α-granule proteins PLT factor (PF)4; osteonectin and thrombospondin (TSP); and housekeeping protein glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were determined using absorbance and quantitative polymerase chain reaction. RESULTS: After treatment, amounts of all analyzed mRNAs were significantly reduced (p < 0.05), but to different degrees. For GAPDH and PF4, transcripts appeared less susceptible to the treatment, with 70% remaining 1 hour after UV illumination. For GPIIIa and TSP, less than 15% remained after treatment. There was a correlation (R(2) = 0.85) between transcript length and amount of mRNA remaining 1 hour after treatment. Total RNA demonstrated a life span equal to the PLT life span of 10 to 11 days. CONCLUSION: This is the first report of the impact of riboflavin and UV illumination on PLT mRNA. Results suggest that all mRNA present in PLTs is affected by the treatment although the degree of the effect varies among transcripts.


Subject(s)
Blood Platelets/metabolism , RNA, Messenger/genetics , Riboflavin/pharmacology , Ultraviolet Rays , Blood Platelets/drug effects , Blood Platelets/radiation effects , Blood Preservation/methods , Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating)/analysis , Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating)/genetics , Humans , Integrin beta3/analysis , Integrin beta3/genetics , Osteonectin/analysis , Osteonectin/genetics , Platelet Factor 4/analysis , Platelet Factor 4/genetics , Platelet Membrane Glycoprotein IIb/analysis , Platelet Membrane Glycoprotein IIb/genetics , RNA, Messenger/drug effects , RNA, Messenger/radiation effects , Thrombospondins/analysis , Thrombospondins/genetics
2.
Angew Chem Int Ed Engl ; 54(46): 13590-3, 2015 Nov 09.
Article in English | MEDLINE | ID: mdl-26368852

ABSTRACT

Transcribing exogenous RNA in eukaryotic cells requires delivering DNA to their nuclei and changing their genome. Nuclear delivery is often inefficient, limiting the potential scope of gene therapy and synthetic biology. These challenges may be overcome by techniques that allow for extranucleate transcription within eukaryotic cells. Protocells have been developed that enable transcription inside of liposomes; however, it has not yet been demonstrated whether this technology can be extended for use within eukaryotic cells. Here we show RNA-synthesizing nanoliposomes allow transcription of exogenous RNA inside anucleate cells. To accomplish this, components of transcription were encapsulated into liposomes and delivered to platelets. These liposomes were capable of light-induced transcription in platelets, providing proof-of-concept that protocell technology can be adapted for use within mammalian cells.


Subject(s)
Artificial Cells/metabolism , Blood Platelets/metabolism , RNA, Messenger/genetics , Transcription, Genetic/genetics , Blood Platelets/cytology , Humans , Liposomes/chemistry , Liposomes/metabolism , Nanoparticles/chemistry , Nanoparticles/metabolism , RNA, Messenger/metabolism
3.
Transfusion ; 53(10): 2287-92, 2013 Oct.
Article in English | MEDLINE | ID: mdl-23362882

ABSTRACT

BACKGROUND: Developing new quality control methods for platelet concentrates (PCs) can contribute to increasing transfusion safety and efficiency. The aim of this study was to investigate in a large field test the quality of expired PCs and whether 100% noninvasive pH monitoring can be used to predict PC quality. STUDY DESIGN AND METHODS: The pH of 13,693 PCs produced for transfusion was monitored daily using Blood Storage, Inc.'s pH sterile, automated fluoroscopic evaluation technology. Upon indication of compromised quality or expiration, PCs were returned and in vitro tests were performed. RESULTS: A total of 998 PCs were returned, of which 962 outdated, 26 had a positive BacT/ALERT reaction, seven had aggregates, one was without swirl, one had low pH, and one had high pH. BacT/ALERT was faster in identifying bacterial contamination than pH measurements. The pH at the end of the storage period was significantly lower than at the beginning. In vitro tests indicated that while the PC quality was acceptable upon expiration, it rapidly declined after expiration. CONCLUSION: In this setting where the vast majority of PCs were of good quality and within acceptable pH limits, daily, noninvasive routine pH measurement has limited added value in identifying quality-compromised PCs.


Subject(s)
Blood Platelets/physiology , Blood Platelets/chemistry , Blood Preservation , Humans , Hydrogen-Ion Concentration , Platelet Transfusion
SELECTION OF CITATIONS
SEARCH DETAIL
...